Joint Filing AgreementJoint Filing Agreement • November 16th, 2020 • Richmond Brothers, Inc. • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G dated November 16, 2020 (including amendments thereto) with respect to the Common Stock, $0.0001 par value, of Ocuphire Pharma, Inc.. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
